Edition:
India

People: DexCom Inc (DXCM.OQ)

DXCM.OQ on NASDAQ Stock Exchange Global Select Market

317.31USD
2:15am IST
Change (% chg)

$-0.90 (-0.28%)
Prev Close
$318.21
Open
$317.57
Day's High
$321.38
Day's Low
$313.42
Volume
165,847
Avg. Vol
316,190
52-wk High
$456.23
52-wk Low
$182.15

Doubleday, Richard 

Mr. Richard B. Doubleday is no longer serves as Executive Vice President, Chief Commercial Officer of the Company effective 12/31/2020. He has served as our Executive Vice President, Chief Commercial Officer since January 2015. From February 2013 to January 2015, Mr. Doubleday served as our Senior Vice President of Worldwide Sales and Marketing. From June 2009 to February 2013, Mr. Doubleday served as our Vice President of Sales. From May 1988 to June 2009, Mr. Doubleday served in various roles for Johnson & Johnson, Inc. (“J&J”), including Director of Marketing for J&J subsidiary Animas Corporation, a manufacturer of insulin pumps, from July 2006 to June 2009, and Field Sales Director for J&J subsidiary LifeScan, Inc., a manufacturer of blood glucose monitoring systems, from August 2002 to October 2005. Mr. Doubleday received a B.A. from Michigan State University.

Basic Compensation

Total Annual Compensation, USD 912,384
Restricted Stock Award, USD 2,344,110
Long-Term Incentive Plans, USD --
All Other, USD 17,694
Fiscal Year Total, USD 3,274,180

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Kevin Sayer

10,279,400

Quentin Blackford

3,806,900

Jake Leach

--

Donald Abbey

2,919,160

Andrew Balo

3,022,690

Richard Doubleday

3,274,180
As Of  31 Dec 2019